Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 27, 2023

SELL
$7.79 - $16.29 $83,236 - $174,058
-10,685 Reduced 40.32%
15,814 $163,000
Q4 2022

Jan 30, 2023

BUY
$11.0 - $21.45 $76,285 - $148,755
6,935 Added 35.45%
26,499 $312,000
Q3 2022

Oct 21, 2022

BUY
$20.09 - $35.8 $502 - $894
25 Added 0.13%
19,564 $411,000
Q2 2022

Jul 26, 2022

BUY
$27.42 - $43.63 $535,759 - $852,486
19,539 New
19,539 $606,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $420M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Sumitomo Mitsui Trust Holdings, Inc. Portfolio

Follow Sumitomo Mitsui Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.